Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion type Assertion NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_head.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion description "[We typed Norwegian MS patients (n = 631) and controls (n = 555) for HLA-A, -B, -C and -DRB1 alleles as well as the presence or absence of genes encoding inhibitory (KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL5, KIR3DL1, KIR3DL2, KIR3DL3) and activating (KIR2DS1, KIR2DS2, KIR2DS3, KIR2DL4, KIR2DS4, KIR2DS5, KIR3DS1) KIRs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_provenance.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion evidence source_evidence_literature NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_provenance.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion SIO_000772 19630074 NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_provenance.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion wasDerivedFrom gad-20150221 NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_provenance.
- NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_assertion wasGeneratedBy ECO_0000203 NP74821.RAJPSQV3gUL889vfTtIgNm47Y0tXE4YW3OCQ_tkQbE9oo130_provenance.